Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain

Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain

ObjectiveTo estimate the economic impact of individualized dose optimization guided by antimicrobial therapeutic drug monitoring (TDM) in Spain, compared to no monitoring.MethodsA cost analysis of antibiotic treatment of critically ill patients, with and without TDM, was performed using a probabilis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Santiago Grau, Sonia Luque, Olivia Ferrandez, Adela Benitez Cano, Darío Rubio-Rodríguez, Carlos Rubio-Terrés
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Subjects:	therapeutic drug monitoring dose optimization antimicrobials critical ill patient economic impact
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1506109/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Cost-Effectiveness of Beta-Lactam Desensitization in the Management of Penicillin-Allergic Patients
by: Alicia Rodríguez-Alarcón, et al.
Published: (2025-06-01)

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
by: Carlos Rubio-Terrés, et al.
Published: (2016-02-01)

PK/PD-Guided Strategies for Appropriate Antibiotic Use in the Era of Antimicrobial Resistance
by: Tetsushu Onita, et al.
Published: (2025-01-01)

Prescribing for change – safer antimicrobial use in hospitals
by: Sean O'Gorman, et al.
Published: (2024-11-01)

Automated dispensing cabinets and the effect on omitted doses of ward stock medicines; can implementation reduce delays to first dose antimicrobials?
by: Emma Jeffrey, et al.
Published: (2025-06-01)

“Adequate dose” in the drug treatment of mental disorders
by: V. L. Kozlovskii, et al.
Published: (2023-07-01)

Therapeutic drug monitoring for antimicrobial agents for people living with HIV (TAP) [version 2; peer review: 2 approved, 1 approved with reservations]
by: Andrew Kambugu, et al.
Published: (2025-04-01)

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis
by: ZHU Jianling, et al.
Published: (2024-12-01)

Impact of Fungal Co-Infection on Teicoplanin Plasma Trough Concentration in Critically Ill Adults: A Novel Consideration for Dose Adjustment
by: Cheng L, et al.
Published: (2025-06-01)

Perspectives of ICU Physicians on Antibiotic Use in Critically Ill Patients: A Qualitative Study from a Developing Country
by: Maheen Khoso, et al.
Published: (2025-06-01)

Effect of Cefotaxime Administration on the kidney, liver and Lung of Swiss white Mice (mus musculus)
by: Asraa Abed Jazaa
Published: (2023-01-01)

Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
by: Todd A. Miano, PharmD, PhD, et al.
Published: (2024-11-01)

Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy
by: Ayse Serra Ozel, et al.
Published: (2019-10-01)

Efficacy of therapeutic-dose heparin for severe COVID-19 patients at COVID-19 Emergency Hospital Jakarta
by: Hari Hendarto, et al.
Published: (2024-07-01)

Evaluation of Potential Drug–Drug Interactions with Antimicrobials among Critically Ill Patients in Intensive Care Units of a Tertiary Care Hospital: A Cross-Sectional Study
by: T. Abhishek, et al.
Published: (2025-05-01)

Population pharmacokinetics of polymyxin B in critically ill patients with carbapenem-resistant organisms infections: insights from steady-state trough and peak plasma concentration
by: Jun Yang, et al.
Published: (2025-03-01)

Bacterial isolates and antibiotic resistance in critically ill sepsis patients at a tertiary hospital in Ethiopia
by: Girum Tesfaye Kiya, et al.
Published: (2025-08-01)

Impact of an antimicrobial time-out program on antimicrobial consumption rate in hospitalized patients: a quasi-experimental study on the national antimicrobial stewardship program in Iran
by: Mohammadreza Salehi, et al.
Published: (2025-05-01)

Commentary: Defining long-term survivors in metastatic lung cancer: insights from a Delphi study in Spain
by: Javier-David Benitez-Fuentes, et al.
Published: (2025-07-01)

Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain
by: Alberto Perez-Rubio, et al.
Published: (2025-03-01)

Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
by: Julie Birdie Wahlang, et al.
Published: (2024-12-01)

A Comparative Cross-sectional Study to Assess Knowledge Regarding Human Rights of Mentally Ill between Patient with Severe Mental Illness and People Without Mental Illness
by: Rashmi Rawat, et al.
Published: (2025-04-01)

Synthetic Biology‐Based Engineering Living Therapeutics for Antimicrobial Application
by: Shun Huang, et al.
Published: (2025-08-01)

Further reflections on chronic illness care
by: Ian Couper
Published: (2007-05-01)

Chronic Illness - The New Opportunity
by: Sam Fehrsen
Published: (2007-05-01)

Reflections on the care of the chronically ill
by: I. Couper
Published: (2003-12-01)

Bacterial Extracellular Vesicles and Antimicrobial Peptides: A Synergistic Approach to Overcome Antimicrobial Resistance
by: Corina Ciobanasu
Published: (2025-04-01)

The Therapeutic Potential of Antimicrobial Peptides Isolated from the Skin Secretions of Anurans of the Genus <i>Boana</i> in the Face of the Global Antimicrobial Resistance Crisis
by: Priscila Mendes Ferreira, et al.
Published: (2025-06-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

Population pharmacokinetics of colistin sulfate in critically ill patients based on NONMEM
by: Qiang Sun, et al.
Published: (2025-05-01)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
by: Santiago Grau, et al.
Published: (2015-10-01)

A qualitative study of illness identity: schizophrenia and depression
by: Namino Ottewell
Published: (2018-08-01)

Biochemical criteria of toxicity of therapy with high doses of methotrexate in children with osteosarcoma
by: A. M. Strizhevskaya, et al.
Published: (2015-06-01)

Antimicrobial stewardship reduces antibiotic use density and cost in a Chinese tertiary hospital
by: Chuanwei Xin, et al.
Published: (2025-07-01)

Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
by: M. Mieresova, et al.
Published: (2023-03-01)

Navigating the patient-provider relationship during severe illness with lessons from a qualitative perspective of calciphylaxis
by: Olivia G. Durant, et al.
Published: (2025-07-01)

THE RESULTS OF INDIVIDUAL DOSE CONTROL OF HEALTH INSTITUTIONS STAFF
by: E. N. Shleenkova
Published: (2015-08-01)

Critical illness polyneuromyopathy (literature review)
by: G. P. Plotnikov, et al.
Published: (2023-10-01)

Enhanced prediction of hemolytic activity in antimicrobial peptides using deep learning-based sequence analysis
by: Ibrahim Abdelbaky, et al.
Published: (2024-11-01)

Prevalence of polypharmacy and pharmacotherapy complexity in elderly people living with HIV in Spain. POINT study
by: Mercedes Gimeno-Gracia, et al.
Published: (2020-07-01)